- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
8
Companies which are more than 50% undervalued based on analyst price target.
8 companies
Caliway Biopharmaceuticals
Market Cap: NT$172.0b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$110.50
7D
1.8%
1Y
-17.8%
Bora Pharmaceuticals
Market Cap: NT$54.0b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$424.00
7D
-0.1%
1Y
-44.6%
Lotus Pharmaceutical
Market Cap: NT$49.5b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$188.50
7D
-0.8%
1Y
-8.0%
Oneness Biotech
Market Cap: NT$22.5b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.
4743
NT$46.85
7D
2.4%
1Y
-30.5%
TaiMed Biologics
Market Cap: NT$18.7b
A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.
4147
NT$68.50
7D
15.9%
1Y
-12.2%
Medigen Vaccine Biologics
Market Cap: NT$16.6b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$50.60
7D
-2.9%
1Y
26.8%
EirGenix
Market Cap: NT$15.5b
Operates as a contract development and manufacturing company in Taiwan and internationally.
6589
NT$51.10
7D
5.0%
1Y
-17.8%
Foresee Pharmaceuticals
Market Cap: NT$12.5b
Operates as biopharmaceutical company in the United States, China, and Europe.
6576
NT$79.50
7D
-0.3%
1Y
6.3%